Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Kidney Int. 2008 Oct 8;75(5):465–474. doi: 10.1038/ki.2008.496

Figure 7. Gd versus ferumoxytol MR pre-operatively and intra-operatively in a glioma patient using a 3 T versus a 0.15 T magnet.

Figure 7

Glioma patient (a) T1-enhancement with GBCA. At 24 h after ferumoxytol infusion, (b) T1 enhancement, (c) T2*-weighted images. (d) Intraoperative T1-weighted 0.15 T MR 26 h after ferumoxytol injection.3 (Reproduced from Neurosurgery 2007; 60: 601−611; discussion 611−602, with permission of Lippincott, Williams & Wilkins, 2008).